DSP-1181, a pharmaceutical drug created by AI technology, has entered phase 1 clinical trials in Japan. This is the first time an AI-made drug has reached this point in the development process.
AI models can be trained to predict outcomes in meningioma patients, according to new research published in npjDigital Medicine. The study’s authors even developed a free smartphone app so others can explore their work.
AI promises to make a titanic impact on radiology, but most of the attention tends to focus on its ability to identify important findings in medical images. What about the technology’s non-interpretive qualities?
In the near future, patients may have their blood drawn and tested by an advanced robot—and it’s a move that would benefit both patients and healthcare providers.
Big-name Chinese technology vendors have responded to the Wuhan coronavirus outbreak by using more AI surveillance on the general public than ever before.
Machine learning-based algorithms can predict how patients will respond to antidepressants, according to new research published in Nature Biotechnology. The secret, the authors revealed, is electroencephalography (EEG) data.